Detailed Information on Publication Record
2020
Micrometastases in Sentinel Lymph Nodes Represent a Significant Negative Prognostic Factor in Early-Stage Cervical Cancer: A Single-Institutional Retrospective Cohort Study
KOCIAN, Roman, Jiri SLAMA, Daniela FISCHEROVA, Anna GERMANOVA, Andrea BURGETOVA et. al.Basic information
Original name
Micrometastases in Sentinel Lymph Nodes Represent a Significant Negative Prognostic Factor in Early-Stage Cervical Cancer: A Single-Institutional Retrospective Cohort Study
Authors
KOCIAN, Roman (203 Czech Republic), Jiri SLAMA (203 Czech Republic), Daniela FISCHEROVA (203 Czech Republic), Anna GERMANOVA (203 Czech Republic), Andrea BURGETOVA (203 Czech Republic), Ladislav DUŠEK (203 Czech Republic, belonging to the institution), Pavel DUNDR, Kristyna NEMEJCOVA (203 Czech Republic), Jiří JARKOVSKÝ (203 Czech Republic, belonging to the institution), Silvie SEBESTOVA (203 Czech Republic), Filip FRUHAUF (203 Czech Republic), Lukas DOSTALEK (203 Czech Republic), Tereza BALLASCHOVA (203 Czech Republic) and David CIBULA (203 Czech Republic, guarantor)
Edition
Cancers, BASEL, MDPI, 2020, 2072-6694
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30204 Oncology
Country of publisher
Switzerland
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 6.639
RIV identification code
RIV/00216224:14110/20:00116113
Organization unit
Faculty of Medicine
UT WoS
000549262500001
Keywords in English
micrometastasis; isolated tumor cells; sentinel lymph node; cervical cancer; pathological ultrastaging; prognostic parameters; risk of recurrence
Tags
International impact, Reviewed
Změněno: 3/8/2020 13:42, Mgr. Tereza Miškechová
Abstract
V originále
The data on the prognostic significance of low volume metastases in lymph nodes (LN) are inconsistent. The aim of this study was to retrospectively analyze the outcome of a large group of patients treated with sentinel lymph node (SLN) biopsy at a single referral center. Patients with cervical cancer, stage T1a-T2b, common tumor types, negative LN on preoperative staging, treated by primary surgery between 01/2007 and 12/2016, with at least unilateral SLN detection were included. Patients with abandoned radical surgery due to intraoperative SLN positivity detected by frozen section were excluded. All SLNs were postoperatively processed by an intensive protocol for pathological ultrastaging. Altogether, 226 patients were analyzed. Positive LN were detected in 38 (17%) cases; macrometastases (MAC), micrometastases (MIC), isolated tumor cells (ITC) in 14, 16, and 8 patients. With the median follow-up of 65 months, 22 recurrences occurred. Disease-free survival (DFS) reached 90% in the whole group, 93% in LN-negative cases, 89% in cases with MAC, 69% with MIC, and 87% with ITC. The presence of MIC in SLN was associated with significantly decreased DFS and OS. Patients with MIC and MAC should be managed similarly, and SLN ultrastaging should become an integral part of the management of patients with early-stage cervical cancer.